UA84292U - Method for treating recurrent herpes - Google Patents

Method for treating recurrent herpes

Info

Publication number
UA84292U
UA84292U UAU201306434U UAU201306434U UA84292U UA 84292 U UA84292 U UA 84292U UA U201306434 U UAU201306434 U UA U201306434U UA U201306434 U UAU201306434 U UA U201306434U UA 84292 U UA84292 U UA 84292U
Authority
UA
Ukraine
Prior art keywords
recurrent herpes
treating recurrent
treating
herpes
nucleinate
Prior art date
Application number
UAU201306434U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Вадим Александрович Терешин
Николай Александрович Пересадин
Игорь Николаевич Баскаков
Елена Михайловна Остапущенко
Лариса Ивановна Бреславец
Original Assignee
Вадим Александрович Терешин
Николай Александрович Пересадин
Игорь Николаевич Баскаков
Елена Михайловна Остапущенко
Лариса Ивановна Бреславец
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Вадим Александрович Терешин, Николай Александрович Пересадин, Игорь Николаевич Баскаков, Елена Михайловна Остапущенко, Лариса Ивановна Бреславец filed Critical Вадим Александрович Терешин
Priority to UAU201306434U priority Critical patent/UA84292U/en
Publication of UA84292U publication Critical patent/UA84292U/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A method for treating the recurrent herpes comprises the use of nucleinate as anti-inflammatory, analgesic and interferon-inducing agent.
UAU201306434U 2013-05-24 2013-05-24 Method for treating recurrent herpes UA84292U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201306434U UA84292U (en) 2013-05-24 2013-05-24 Method for treating recurrent herpes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201306434U UA84292U (en) 2013-05-24 2013-05-24 Method for treating recurrent herpes

Publications (1)

Publication Number Publication Date
UA84292U true UA84292U (en) 2013-10-10

Family

ID=52283645

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201306434U UA84292U (en) 2013-05-24 2013-05-24 Method for treating recurrent herpes

Country Status (1)

Country Link
UA (1) UA84292U (en)

Similar Documents

Publication Publication Date Title
PH12019501321A1 (en) Methods of treating or preventing cholesterol related disorders
EP4230264A3 (en) Prodrugs of fumarates and their use in treating various deseases
EP4282479A3 (en) Use of pridopidine to treat depression or anxiety
IN2013MU03646A (en)
DK2922828T3 (en) 4,6-DIAMINO-PYRIMIDINE DERIVATIVES AS BMI-1 INHIBITORS TO TREAT CANCER
MX2020001756A (en) Benzoquinolone inhibitors of vmat2.
EP3026140A4 (en) Steel plate for line pipe, and line pipe
AU2015299431B2 (en) Pyrrolidinone derivatives as metAP-2 inhibitors
WO2014153495A3 (en) Novel stat3 inhibitors
MX366765B (en) Ppar? agonists for treatment of multiple sclerosis.
MX2021007899A (en) Selective il-6-trans-signalling inhibitor compositions.
CA2875305C (en) Fbxo3 inhibitors
NZ730816A (en) Quinoline carboxamides for use in the treatment of multiple myeloma
WO2014146111A3 (en) Analgesic compounds and methods of use
MX2015013021A (en) 5-bromo-indirubins.
NZ732704A (en) Quinoline carboxamides for use in the treatment of leukemia
PT2941443T (en) Method for immediately terminating radical polymerizations, inhibitor solution, and use thereof
WO2015134603A3 (en) Methods for treating cancer
EP3560914A4 (en) Sulfonyl amidine as indoleamine-2,3-dioxygenase inhibitor, and preparation method therefor and use thereof
MX2019005723A (en) Fgfr4 inhibitor and preparation method and use thereof.
GB2543709A (en) Pharmaceutical agent
UA84292U (en) Method for treating recurrent herpes
MX2018002193A (en) Quinoxalinyl-piperazinamide methods of use.
UA75455U (en) Method for preventing prosthesis-caused stomatitis
UA100326U (en) Use of sodium salt of hydrogen sulfide for potentiating analgesic effect of non-steroid anti-inflammatory drugs